Naderi, S., Acar, F., Mertol, T
For patients eager to start treatment, this speed is competitive with the fastest providers in the space
While it is difficult to take a stance on the timing with which individual therapies will cross specific regulatory, cost, and adoption thresholds, the totality of innovation progress in these areas could drive an acceleration in the pace of health progress
Benefits may reverse if the medication is stopped, often leading to weight regain and blood sugar spikes meaning these are not short-term interventions for most people who take them
Survey respondents were still quick to judge the fictional people for regaining weight, but they didn't seem to care whether they had used GLP-1s or followed a diet and exercise regimen to lose it in the first place